1. Home
  2. UNF vs RNA Comparison

UNF vs RNA Comparison

Compare UNF & RNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • UNF
  • RNA
  • Stock Information
  • Founded
  • UNF 1936
  • RNA 2012
  • Country
  • UNF United States
  • RNA United States
  • Employees
  • UNF N/A
  • RNA N/A
  • Industry
  • UNF Business Services
  • RNA Biotechnology: Pharmaceutical Preparations
  • Sector
  • UNF Consumer Discretionary
  • RNA Health Care
  • Exchange
  • UNF Nasdaq
  • RNA Nasdaq
  • Market Cap
  • UNF N/A
  • RNA 3.7B
  • IPO Year
  • UNF N/A
  • RNA 2020
  • Fundamental
  • Price
  • UNF $173.77
  • RNA $31.60
  • Analyst Decision
  • UNF Hold
  • RNA Strong Buy
  • Analyst Count
  • UNF 3
  • RNA 12
  • Target Price
  • UNF $189.67
  • RNA $68.25
  • AVG Volume (30 Days)
  • UNF 139.4K
  • RNA 1.3M
  • Earning Date
  • UNF 04-02-2025
  • RNA 05-08-2025
  • Dividend Yield
  • UNF 0.81%
  • RNA N/A
  • EPS Growth
  • UNF 30.73
  • RNA N/A
  • EPS
  • UNF 7.82
  • RNA N/A
  • Revenue
  • UNF $2,438,814,000.00
  • RNA $10,897,000.00
  • Revenue This Year
  • UNF $1.09
  • RNA N/A
  • Revenue Next Year
  • UNF $3.83
  • RNA $230.08
  • P/E Ratio
  • UNF $22.24
  • RNA N/A
  • Revenue Growth
  • UNF 6.74
  • RNA 13.98
  • 52 Week Low
  • UNF $149.58
  • RNA $21.56
  • 52 Week High
  • UNF $243.70
  • RNA $56.00
  • Technical
  • Relative Strength Index (RSI)
  • UNF 27.30
  • RNA 50.31
  • Support Level
  • UNF $162.00
  • RNA $30.12
  • Resistance Level
  • UNF $180.60
  • RNA $33.13
  • Average True Range (ATR)
  • UNF 5.33
  • RNA 2.14
  • MACD
  • UNF -3.34
  • RNA 0.14
  • Stochastic Oscillator
  • UNF 24.50
  • RNA 35.92

About RNA Avidity Biosciences Inc.

Avidity Biosciences Inc is a biotechnology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product, AOC 1001, is designed to treat a rare monogenic muscle disease.

Share on Social Networks: